Pharma Tariffs & The So-Called "Big Beautiful Bill” with Alex Durante - Part 2

In Part Two of our conversation, Bill Bernardoni continues with Alex Durante, Senior Economist at the Tax Foundation and former member of Trump’s Council of Economic Advisers. We dig into the proposed pharmaceutical tariffs—what they could mean for generic drugs, innovation, and your prescription costs—and then unpack “the one big beautiful bill.” From permanent pro-investment incentives to deficit-driving giveaways, Alex gives the Tax Foundation’s take on what’s good, what’s bad, and what’s downright ugly in the new tax law.Do you think tax reform should prioritize investment incentives or direct breaks for groups like tipped workers and seniors? Where should lawmakers draw the line between growth and giveaways?Follow Bill on X at @BillBernardoni, explore his work at Bernardoni.media, and read his latest writings at Bernardoni.blog.